Lower Antioxidant Level Might Explain Higher Skin-Cancer Rate In Males
12/03/2011
Men are three times more likely than women to develop a common form of skin cancer but medical science doesn't know why. A new study may provide part of the answer. Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J...
New 'Achilles' Heel' In Breast Cancer: Tumor Cell Mitochondria
12/03/2011
Researchers at the Kimmel Cancer Center at Jefferson have identified cancer cell mitochondria as the unsuspecting powerhouse and "Achilles' heel" of tumor growth, opening up the door for new therapeutic targets in breast cancer and other tumor types. Reporting in the online Dec.1 issue of Cell Cycle, Michael P. Lisanti, M.D., Ph.D...
A meta-analysis published Online First in The Lancet shows that patients who self-monitor their blood-thinning (oral anticoagulation) therapy with vitamin K antagonists (VKA), such as warfarin, almost halve their risk of developing thromboembolic events like stroke, deep vein thrombosis and heart attack compared with those who receive traditional care...
Tumor-Targeting Compound Points The Way To New Personalized Cancer Treatments
12/02/2011
One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments geared toward the targeting of specific cancer-causing mechanisms is hampered by lack of knowledge of the molecular pathways that drive cancers in individual patients...
Researchers Find New Path To Control Tumor Growth
12/02/2011
New evidence by University of Alabama at Birmingham researchers that specific electromagnetic fields can safely block the proliferation of cancer cells and tumor growth may help refine a new, targeted therapy without any collateral damage...
Exercise Benefits Breast Cancer Survivors, Patients With Lymphedema, Say Researchers
12/02/2011
After reviewing published evidence, University of Missouri researchers conclude the benefits of exercise outweigh the risks for breast cancer survivors, including those who develop lymphedema, a chronic swelling that commonly occurs after breast cancer treatment...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the cobas EGFR Mutation Test is now CE marked for commercial availability in Europe and other countries that recognize CE mark...
In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients. The effect, in some cases, was profound. The phase I study, published in the Dec...
Soft-Tissue Sarcoma: Unlocking The Genetic And Molecular Mystery
12/02/2011
Scientists at Joslin Diabetes Center in Boston have uncovered important molecular and genetic keys to the development of soft-tissue sarcomas in skeletal muscle, giving researchers and clinicians additional targets to stop the growth of these often deadly tumors...
Genome-Wide Study Into New Gene Functions In The Formation Of Platelets
12/02/2011
In a study into the genetics of blood cell formation, researchers have identified 68 regions of the genome that affect the size and number of platelets. Platelets are small cells that circulate in the blood and are key to the processes of blood clotting and wound healing...